Tyson named chair of Executive Leadership Council

Tuesday, January 31, 2012 07:51 AM

Bernard Tyson, president and COO of Kaiser Permanente, has been named chair of the Executive Leadership Council (ELC)—a preeminent organization composed of African-American senior executives from the nation's Fortune 500 corporations that recognizes the strengths, success, contributions and impact of African-American business leaders. His term runs through Dec. 31, 2013.

"As chair, my role is to harness the collective energy and intellect of the ELC for the benefit of corporate America," Tyson said. "We must continue our focus on increasing the presence of highly qualified, capable and competent African-Americans at the CEO level or one to two levels below and on the boards of publicly-traded companies."

Tyson has been recognized for his work both within and outside of health care. In 2010 he was named one of the 25 most influential African Americans in health care by Black Health magazine, and one of the top 25 minority executives in the nation by Modern Healthcare. He currently serves on the board of the American Heart Association and Occidental College in Los Angeles, and is engaged in many philanthropic and community-based events.

"Bernard is an extremely effective leader with a demonstrated track record of achievement through collaboration, inclusion and acceptance," said George C. Halvorson, chairman and CEO of Kaiser Permanente. "His methods have produced very powerful outcomes within Kaiser Permanente. I am certain he will bring the same spirit to the ELC."

Arnold W. Donald, president and CEO of the ELC, said, "Bernard has been a very active member [of ELC] for many years, and we look forward to benefiting from his knowledge, creativity and guidance as we advance our efforts to increase African-American leadership at the most senior levels and on the boards of America's largest corporations.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs